Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Robert Califf

Morning Brief: Top Financial Stories Dominating on Monday, May 16

CNBC Volkswagen CEO Shares Ambitious EV Ambitions For US Market

Benzinga

Infant formula shortage suddenly Topic A in Washington

The problem has been brewing for months, but politicians in both parties have recently seized on the issue, as the White House scrambles to ease the crunch.

Politico

White House bolsters efforts to get baby formula into the hands of WIC recipients

States have been asked to increase accessibility of baby formula for recipients of the low-income program. And the Food and Drug Administration is looking at ways to make it easier to import formula.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

Tainted baby-formula risk was seen months before Abbott’s recall

Federal inspectors spotted the potential for baby formula made at an Abbott Laboratories plant to become contaminated months before a recall that exacerbated a nationwide shortage, a government document shows.

Tribune News Service

FDA says it is "doing everything in our power" to improve baby formula supply

The shortage has intensified in recent weeks due to supply chain issues and a devastating recall.

Axios

Pressure builds for COVID vaccines approval for littlest kids

Moderna's request for approval of its COVID -19 vaccine in children under six years amps up pressure on the Food and Drug Administration to act quickly to approve the shots.

Axios

FDA proposes ban on menthol cigarettes

FDA commissioner Robert Califf said these rules "are appropriate for the protection of public health."

Axios

Read news from The Economist, FT, and more,
with one subscription

Outlook poses tough questions for next steps on COVID-19 vaccines

Preparations for another potential round of COVID-19 vaccines are prompting more questions than answers as federal health officials contend with the threat of future variants amid waning public interest in additional shots.

Tribune News Service

Outlook poses tough questions for next steps on COVID-19 vaccines - Roll Call

Health care officials face tough questions as they set policy to deal with the next phase of the pandemic and try to get the messaging right.

Roll Call

Can the FDA's New Commissioner Save the Agency From Itself?

Robert Califf must demand transparency and accountability from the bureaucrats.

Reason

22nd Century Group Welcomes Dr. Robert Califf's Confirmation As FDA Commissioner

22nd Century Group, Inc. (NASDAQ: XXII) an agricultural biotechnology company focused on tobacco harm reduction, congratulated Dr.

Benzinga

US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time

By a narrow vote of 50-46, the Senate has confirmed Robert Califf to run the FDA.

Benzinga

Senate confirms Robert Califf to become Biden’s FDA commissioner

WASHINGTON — The Senate on Tuesday confirmed Robert Califf to lead the Food and Drug Administration, 50-46, a much narrower vote than when he previously held the position during the Obama administration, though many thought the latest vote could be even closer.

Tribune News Service

Califf confirmed: The 6 challenges that await the new FDA commissioner

Returning to the FDA early in President Joe Biden's tenure gives Califf greater ability to place his stamp on the agency than the last time he led it.

Politico

Get all your
news in one place.

100’s of premium titles.
One news app.

Axios

Senate confirms Robert Califf as FDA commissioner

The agency has been without a permanent leader for more than a year.

Roll Call

Senate confirms Califf to become Biden's FDA commissioner - Roll Call

Six Republicans voted Tuesday to confirm FDA nominee Robert Califf, who had seen opposition from pockets of the Democratic caucus.

The Guardian - US

Jury finds New York Times did not defame Sarah Palin – as it happened

Former Republican vice-presidential nominee sued the newspaper in 2017 claiming an editorial damaged her career

Roll Call

Senate sets up Califf confirmation vote with narrow procedural win - Roll Call

The nominee to lead the FDA, Robert Califf, survived a Senate procedural vote Monday with the help of five Republicans.

Get all your
news in one place.

100’s of premium titles.
One news app.

Politico

Schumer moves to limit debate on Califf nomination

The Senate is expected to officially vote on his confirmation as early as Tuesday, three people with knowledge of the matter said.

The Independent UK

FDA's agenda in limbo as Biden's nominee stalls in Senate

President Joe Biden’s pick to lead the powerful Food and Drug Administration has stalled in the narrowly divided Senate

Tribune News Service

Wyden probes FDA nominee’s views on accelerated drug approvals

WASHINGTON — Senate Finance Chair Ron Wyden, D-Ore., is pressing the White House’s nominee to lead the Food and Drug Administration, Robert Califf, to pledge to crack down on drugmakers’ use of fast-track approval pathways as the nominee seeks the chairman’s support.

Roll Call

Wyden probes FDA nominee's views on accelerated drug approvals - Roll Call

Support from Wyden could be crucial to Robert Califf's FDA confirmation amid concerns from other Senate Democrats.

Politico

Top Republican throws cold water on struggling FDA nominee

A White House spokesperson said Califf has met with 33 senators to date and is scheduled to meet with an additional 14 so far.

Politico

Biden’s FDA pick makes major ethics pledges to win over Elizabeth Warren

The Massachusetts Democrat is agreeing to back Biden’s FDA pick after he put restrictions on the work he’d do and employment he’d seek.

Politico

‘The White House isn’t supporting him’: Biden’s FDA pick left in limbo

Robert Califf’s supporters fear his candidacy is on the brink — raising the threat of a setback for Biden and the health agency at the center of his pandemic response.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.